7,8-二甲基-10-甲酰基甲基异咯嗪 、
4-Boc-氨甲基哌啶 、
溶剂黄146 、
氰基硼氢化钠 在
((1-(2-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)ethyl)piperidin-4-yl)methyl)carbamamic acid tert-butyl ester 作用下,
以
甲醇 为溶剂,
反应 26.0h,
以Lyophilization of combined fractions affords desired product, tert-butyl ((1-(2-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)ethyl)piperidin-4-yl)methyl)carbamate (104 mg, 62%) as a bright, yellow solid的产率得到((1-(2-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)ethyl)piperidin-4-yl)methyl)carbamamic acid tert-butyl ester